Drug intelligence / Profile preview

iPACK-based multimodal analgesic regimen

Development stage
Unknown
Lead developer
University Health Network
Modality
Small Molecules
Administration
Percutaneous
01

Overview

The iPACK-based multimodal analgesic regimen is a clinical protocol developed by the University Health Network (UHN) in Toronto to manage postoperative pain and reduce opioid consumption following total knee arthroplasty (TKA). This multimodal approach integrates regional anesthesia techniques with systemic non-opioid medications to provide synergistic pain relief. The regional components include an Adductor Canal Block (ACB) and an iPACK (Infiltration between the Popliteal Artery and the posterior Capsule of the Knee) block, both of which utilize local anesthetics to target specific sensory nerves around the knee. Systemic administration involves intraoperative intravenous dexmedetomidine (an alpha-2 adrenergic agonist) and ketamine (an NMDA receptor antagonist) for sedation and analgesia, followed by postoperative intravenous dexamethasone (a corticosteroid) to mitigate inflammation and enhance recovery.

Other names
IPACK and multi-modal analgesic regimenOpioid Sparing Analgesic Strategies for TKA regimeniPACK block regimen
02

Targets

NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on iPACK-based multimodal analgesic regimen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on iPACK-based multimodal analgesic regimen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call